Risk factors for colorectal cancer following breast cancer

Breast Cancer Research and Treatment

Volumn 79, Issue 2, 2003, Pages 143-147

  Kmet, Leanne M ^a   Cook, Linda S ^a,b,c   Weiss, Noel S ^c,d   Schwartz, Stephen M ^c,d   White, Emily ^c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Division of Epidemiology   (Canada)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast neoplasms; Colorectal neoplasms; Second primary neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK; RISK FACTOR;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; POPULATION SURVEILLANCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; WASHINGTON;

EID: 0037680548     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023926401227     Document Type: Article

References (38)

1. Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV: Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 84: 435-440, 2001
2. Newschaffer CJ, Topham A, Herzberg T, Weiner S, Weinberg DS: Risk of colorectal cancer after breast cancer. Lancet 357: 837-840, 2001
3. Levi F, Randimbison L, Te VC, La Vecchia C: Second primary cancers in breast cancer patients in Vaud, Switzerland. Cancer Causes Control 9: 463-464, 1998
4. Volk N, Pompe-Kirn V: Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8: 764-770, 1997
5. Schwartz AG, Ragheb NE, Swanson GM, Satariano WA: Racial and age differences in multiple primary cancers after breast cancer: a population-based analysis. Breast Cancer Res Treat 14: 245-254, 1989
6. Adami HO, Bergkvist L, Krusemo U, Persson I: Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study. J Natl Cancer Inst 73: 1049-1055, 1984
7. Brenner H, Siegle S, Stegmaier C, Ziegler H: Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987. Eur J Cancer 29A: 1410-1414, 1993
8. Murakami R, Hiyama T, Hanai A, Fujimoto I: Second primary cancers following female breast cancer in Osaka, Japan - a population-based cohort study. Jpn J Clin Oncol 17: 293-302, 1987
9. Schoenberg BS, Greenberg RA, Eisenberg H: Occurrence of certain multiple primary cancers in females. J Natl Cancer Inst 43: 15-32, 1969
10. Teppo L, Pukkala E, Saxen E: Multiple cancer - an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207-217, 1985
11. Buiatti E, Crocetti E, Acciai S, Gafa L, Falcini F, Milandri C, La Rosa M: Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 33: 1829-1834, 1997
12. Bordin GM, Key CR, McQuade CE, Kutvirt DM, Hughes WB, Brylinski DA: Multiple primary cancers: relative risk in New Mexico's triethnic population. Cancer 40: 1793-1800, 1977
13. Neugut AI, Murray TI, Lee WC, Robinson E: The association of breast cancer and colorectal cancer in men. An analysis of surveillance, epidemiology, and end results program data. Cancer 68: 2069-2073, 1991
14. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935-1982. National Cancer Institute Monographs 68: 99-112, 1985
15. Cook LS, Weiss NS, Pharris-Ciurej N, Schwartz SM, White E: Colorectal cancer following tamoxifen therapy for breast cancer (United States). Cancer Causes Control 12: 405-410, 2001
16. Doherty MA, Rodger A, Langlands AO, Kerr GR: Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol 26: 125-131, 1993
17. Rubagotti A, Perrotta A, Casella C, Boccardo F: Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer. Ann Oncol 7: 239-244, 1996
18. Valagussa P, Moliterni A, Terenziani M, Zambetti M, Bonadonna G: Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 5: 803-808, 1994
19. Arriagada R, Rutqvist LE: Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet 338: 535-538, 1991
20. Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y: Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 11: 1537-1543, 2000
21. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: National Institutes of Health, National Heart, Lung, and Blood Institute, June 1998
22. Breslow NE, Day NE: Statistical Methods in Cancer Research. International Agency for Research on Cancer, Lyon. 1980
23. Potter JD, Slattery ML, Bostick RM, Gapstur SM: Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545, 1993
24. Slattery ML, Kerber RA: Family history of cancer and colon cancer risk: the Utah Population Database. J Natl Cancer Inst 86: 1618-1626, 1994
25. Foulkes WD, Bolduc N, Lambert D, Ginsburg O, Olien L, Yandell DW, Tonin PN, Narod SA: Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon. J Med Genet 33: 534-539, 1996
26. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608, 1994
27. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695, 1994
28. Johannsson O, Loman N, Moller T, Kristoffersson U, Borg A, Olsson H: Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer 35: 1248-1257, 1999
29. Lin KM, Ternent CA, Adams DR, Thorson AG, Blatchford GJ, Christensen MA, Watson P, Lynch HT: Colorectal cancer in hereditary breast cancer kindreds. Dis Colon Rectum 42: 1041-1045, 1999
30. Peelen T, de Leeuw W, van Lent K, Morreau H, van Eijk R, van Vliet M, Wijnen J, Ligtenberg M, Ginjaar HB, Zweemer R, Menko F, Fodde R, van Ommen GJ, Vasen HF, Cornelisse CJ, Devilee P: Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis. Int J Cancer 88: 778-782, 2000
31. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408, 1997
32. Anonymous: Cancer risks in BRCA2 mutation carriers: The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91: 1310-1316, 1999
33. Lynch HT, Guirgis H, Swartz M, Lynch J, Krush AJ, Kaplan AR: Genetics and colon cancer. Arch Surg 106: 669-675, 1973
34. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J: Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77: 1836-1843, 1996
35. Frank TS: Hereditary cancer syndromes. Arch Pathol Lab Med 125: 85-90, 2001
36. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333, 2002
37. Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I: Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology 10: 476-480, 1999
38. Franceschi S, Gallus S, Talamini R, Tavani A, Negri E, La Vecchia C: Menopause and colorectal cancer. Br J Cancer 82: 1860-1862, 2000